PAUL D'SYLVA

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Inhibitor Therapeutics, Inc.

Filing Date Source Excerpt
2007-01-08 As of the completion of the Acquisition, CBI's Board of Directors and executive officers will be as follows: Paul D'Sylva, 37, CEO and Director
2007-04-12 PAUL D'SYLVA Chief Executive Officer and Director Age 6 37 Director since 2007 Dr. D'Sylva assumed the position of Chief Executive Officer of the Company in January 2007.

Data sourced from SEC filings. Last updated: 2026-03-05